Pfizer CEO Albert Bourla reportedly is planning to meet with Starboard Value after the activist investor took a $1 billion ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

With one headline, Pfizer had gone from being a well-known hunter — spending heavily to buy rivals — to the hunted.

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and ...